Please login to the form below

Not currently logged in
Email:
Password:

Kyowa Kirin

This page shows the latest Kyowa Kirin news and features for those working in and with pharma, biotech and healthcare.

CHMP rejects Kyowa Kirin’s Parkinson’s disease drug

CHMP rejects Kyowa Kirin’s Parkinson’s disease drug

The European Medicines Agency’s (EMA) Comittee for Medicinal Products for Human Use (CHMP) has rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant, despite the treatment being approved in the ... with Parkinson’s, an area which has had few

Latest news

More from news
Approximately 5 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Reaching patients and HCPs during the pandemic Reaching patients and HCPs during the pandemic

    execute a successful virtual launch if it is going to compete with drugs such as Inbrija (Acorda Therapeutics), Nourianz (Kyowa Kirin), and Ongentys (Neurocrine Biosciences).

  • Deal Watch March 2016 Deal Watch March 2016

    $110. AstraZeneca/ Kyowa Hakko Kirin. Opioid-induced constipation – Moventig. Licence. $70.

  • Pharma deals in July 2015 Pharma deals in July 2015

    AZ originally licensed the rights to the molecule from BioWa, a subsidiary of Kyowa Hakko Kirin, in all countries except Japan and certain countries in Asia. ... Still in Japan, a week later AZ agreed a joint venture with Fujifilm Kyowa Kirin Biologics

  • Pharma deals during July 2014 Pharma deals during July 2014

    announced during July was that between AZ and Kyowa Hakko Kirin (KHK) for a co-funded phase 1/1b immuno-oncology study to evaluate two separate combinations of three immunotherapeutic antibodies

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • IGNIFI IGNIFI

    Kyowa Kirin. Sobi. Theramex. Veriton Pharma. Vifor Pharma.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....